|
Report No. : |
334756 |
|
Report Date : |
04.08.2015 |
IDENTIFICATION DETAILS
|
Name : |
NATUS
MANUFACTURING LIMITED |
|
|
|
|
Formerly Known As : |
VIASYS IRELAND HOLDINGS LIMITED |
|
|
|
|
Registered Office : |
IDA Business Park, Gort, Co Galway 264005 |
|
|
|
|
Country : |
Ireland |
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Date of Incorporation : |
30.06.2006 |
|
|
|
|
Legal Form : |
Not Available |
|
|
|
|
Line of Business : |
Subject is engaged in manufacture of medical
and dental instruments and supplies |
|
|
|
|
No. of Employee : |
58 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made on
e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Ireland |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
IRELAND - ECONOMIC OVERVIEW
Ireland is a small, modern, trade-dependent economy. Ireland was among the initial group of 12 EU nations that began circulating the euro on 1 January 2002. GDP growth averaged 6% in 1995-2007, but economic activity dropped sharply during the world financial crisis and the subsequent collapse of its domestic property market and construction industry. Faced with sharply reduced revenues and a burgeoning budget deficit from efforts to stabilize its fragile banking sector, the Irish Government introduced the first in a series of draconian budgets in 2009. These measures were not sufficient to stabilize Ireland’s public finances. In 2010, the budget deficit reached 32.4% of GDP - the world's largest deficit, as a percentage of GDP. In late 2010, the former COWEN government agreed to a $92 billion loan package from the EU and IMF to help Dublin recapitalize Ireland’s banking sector and avoid defaulting on its sovereign debt. In March 2011, the KENNY government intensified austerity measures to meet the deficit targets under Ireland's EU-IMF bailout program. In late 2013, Ireland formally exited its EU-IMF bailout program, benefiting from its strict adherence to deficit-reduction targets and success in refinancing a large amount of banking-related debt. In 2014, the economy rapidly picked up and GDP grew by 3.6%. The recovering economy assisted lowering the deficit to 4.2% of GDP. In late 2014, the government introduced a fiscally neutral budget, marking the end of the austerity program. In the wake of the collapse of the construction sector and the downturn in consumer spending and business investment, the export sector, dominated by foreign multinationals, has become an even more important component of Ireland's economy. Ireland’s low corporation tax of 12.5% has been central to encouraging business investment. Loose tax residency requirements made Ireland a common destination for international firms seeking to avoid taxation. Amid growing international pressure the government announced it would phase in more stringent tax laws, effectively closing a loophole.
|
Source
: CIA |
NATUS
MANUFACTURING LIMITED
Company
Summary
|
|
||
|
Registered Address |
IDA BUSINESS PARK |
Trading Address |
ARTHUR COX BUILDING |
|
|
GORT |
|
EARLSFORT TERRACE |
|
|
CO GALWAY |
|
DUBLIN 2 |
|
|
264005 |
|
DUBLIN 2 |
|
|
|
|
999930 |
|
Website Address |
- |
|
|
|
Telephone Number |
|
Fax Number |
|
|
TPS |
No |
FPS |
No |
|
Incorporation Date |
30/06/2006 |
|
|
|
Previous Name |
VIASYS IRELAND HOLDINGS |
Type |
Other |
|
|
LIMITED |
|
|
|
FTSE Index |
- |
Date of Change |
- |
|
Filing Date of Accounts |
- |
Currency |
EUR |
|
Share Capital |
€1,772,650 |
SIC07 |
32500 |
|
Charity Number |
- |
SIC07 Description |
|
|
Principal Activity – MANUFACTURE OF MEDICAL AND DENTAL
INSTRUMENTS AND SUPPLIES The manufacture and distribution of
healthcare diagnostics products. |
|||
|
Year to Date |
Turnover |
Pre Tax Profit |
Shareholder |
Funds Employees |
|
31/12/2013 |
€15,459,739 |
€5,301,460 |
€2,633,820 |
58 |
|
31/12/2012 |
€20,933,063 |
€1,950,655 |
-€2,490,910 |
95 |
|
31/12/2011 |
€20,594,413 |
€443,653 |
-€4,312,003 |
108 |
Mortgage
Summary
|
|
|
|
|
|
Total Mortgage |
0 |
|
Outstanding |
0 |
|
Satisfied |
0 |
Trade
Debtors / Bad Debt Summary
|
|
|
|
|
|
Total Number of Documented Trade |
0 |
|
Total Value of Documented Trade |
€0 |
No exact match CCJs are recorded
against the company.
The company's credit rating has
increased from 90 to 97 which
indicates very good creditworthiness. The credit
limit on this company has risen
108.3% in comparison to the previously
suggested credit limit. Net Worth increased by
205.7% during the latest trading period.
A 36% growth in Total Assets
occurred during the latest trading period.
|
Total Number of Exact CJs - |
0 |
Total Value of Exact CJs - |
€0 |
|
Total Number of Possible CJs - |
0 |
Total Value of Possible CJs - |
€0 |
|
Total Number of Satisfied CJs - |
0 |
Total Value of Satisfied CJs - |
€0 |
|
Total Current Directors |
2 |
|
|
Total Current Secretaries |
1 |
|
|
Total Previous Directors / Company |
12 |
|
|
Secretaries |
||
Current
Directors
|
|||
|
Name |
SEAN DAVID LANGAN |
Date of Birth |
19/08/1980 |
|
Officers Title |
|
Nationality |
|
|
Present Appointments |
2 |
Function |
Director |
|
Appointment Date |
01/01/2010 |
|
|
|
Address |
CAHERLISTRANE, CO.GALWAY |
|
|
|
Name |
MARKUS MOENKHOFF |
Date of Birth |
15/04/1969 |
|
Officers Title |
|
Nationality |
|
|
Present Appointments |
1 |
Function |
Director |
|
Appointment Date |
01/07/2012 |
|
|
|
Address |
|
25 JOSEF-HEPPNER STR, PULLACH, 82049, GERMANY |
|
Current
Company Secretary
|
|||
|
Name |
SINEAD CASSERLY |
Date of Birth |
20/10/1980 |
|
Officers Title |
|
Nationality |
|
|
Present Appointments |
1 |
Function |
Company Secretary |
|
Appointment Date |
02/10/2013 |
|
|
|
Address |
|
MIRAH, TURLOUGHMORE, ATHENRY, CO GALWAY |
|
Top
20 Shareholders
|
||||
|
|
|
|
|
|
|
Name |
CurrencyShare |
Share |
Nominal |
% of Total Share Count |
|
|
Count |
Type |
Value |
|
|
NATUS HEALTHCARE TECHNOLOGIES IRELAND HOLDING II LTD |
EUR |
1,772,650 |
ORDINARY1 |
100 |
|
Date Of |
31/12/13 |
(%) |
31/12/12 |
(%) |
31/12/11 |
(%) |
31/12/10 |
(%) |
31/12/09 |
|
Accounts |
|
|
|
|
|
|
|
|
|
|
Weeks |
52 |
(%) |
52 |
(%) |
52 |
(%) |
52 |
(%) |
52 |
|
Currency |
EUR |
(%) |
EUR |
(%) |
EUR |
(%) |
EUR |
(%) |
EUR |
|
Consolidated |
|
|
|
|
|
|
|
|
|
|
|
N |
(%) |
N |
(%) |
N |
(%) |
N |
(%) |
N |
|
A/cs |
|
|
|
|
|
|
|
|
|
|
Turnover |
€15,459,739 |
-26.1% |
€20,933,063 |
1.6% |
€20,594,413 |
13.7% |
€18,106,554 |
6.7% |
€16,961,926 |
|
Export |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Cost
of Sales |
€9,724,147 |
-46.8% |
€18,271,144 |
4.8% |
€17,442,251 |
7.1% |
€16,285,338 |
10.3% |
€14,769,076 |
|
Gross
Profit |
€5,735,592 |
115.5% |
€2,661,919 |
-15.6% |
€3,152,162 |
73.1% |
€1,821,216 |
-16.9% |
€2,192,850 |
|
Wages & |
€2,886,268 |
-41.3% |
€4,913,996 |
5.7% |
€4,648,256 |
0.1% |
€4,641,689 |
11.6% |
€4,158,410 |
|
Salaries |
|
|
|
|
|
|
|
|
|
|
Directors |
|
|
|
|
|
|
|
|
|
|
|
€134,848 |
-2.6% |
€138,510 |
25.7% |
€110,191 |
-34.6% |
€168,412 |
237% |
€49,967 |
|
Emoluments |
|
|
|
|
|
|
|
|
|
|
Operating
Profit |
€5,501,742 |
431.4% |
€1,035,261 |
33% |
€778,660 |
170.6% |
-€1,102,787 |
-293.4% |
€570,069 |
|
Depreciation |
€150,658 |
-57.9% |
€357,584 |
-36% |
€558,578 |
-9.8% |
€619,265 |
1.1% |
€612,577 |
|
Audit
Fees |
€24,000 |
- |
€24,000 |
-14.3% |
€28,000 |
- |
€28,000 |
- |
€28,000 |
|
Interest |
|
|
|
|
|
|
|
|
|
|
|
€99,244 |
-43.7% |
€176,268 |
-47.4% |
€335,007 |
49.2% |
€224,492 |
-41.9% |
€386,611 |
|
Payments |
|
|
|
|
|
|
|
|
|
|
Pre
Tax Profit |
€5,301,460 |
171.8% |
€1,950,655 |
339.7% |
€443,653 |
133.4% |
-€1,327,279 |
-823.5% |
€183,458 |
|
Taxation |
-€176,730 |
-36.4% |
-€129,562 |
-173.3% |
€176,782 |
948% |
-€20,848 |
- |
- |
|
Profit
After Tax |
€5,124,730 |
181.4% |
€1,821,093 |
193.5% |
€620,435 |
146% |
-€1,348,127 |
-834.8% |
€183,458 |
|
Dividends
Payable
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Retained
Profit |
€5,124,730 |
181.4% |
€1,821,093 |
193.5% |
€620,435 |
146% |
-€1,348,127 |
-834.8% |
€183,458 |
|
Date Of |
31/12/13 |
(%) |
31/12/12 |
(%) |
31/12/11 |
(%) |
31/12/10 |
(%) |
31/12/09 |
|
Accounts |
|
|
|
|
|
|
|
|
|
|
Tangible Assets |
€1,240,360 |
-4.8% |
€1,303,292 |
-75% |
€5,208,623 |
-5.8% |
€5,527,584 |
-8% |
€6,005,610 |
|
Intangible |
|
|
|
|
|
|
|
|
|
|
Assets |
0 |
- |
0 |
-100% |
€421,181 |
-63.9% |
€1,168,306 |
-42.3% |
€2,025,928 |
|
Total Fixed |
€1,240,360 |
-4.8% |
€1,303,292 |
-76.9% |
€5,629,804 |
-15.9% |
€6,695,890 |
-16.6% |
€8,031,538 |
|
Assets |
|
|
|
|
|
|
|
|
|
|
Stock |
€3,193,313 |
10% |
€2,901,829 |
-36.1% |
€4,543,658 |
71.4% |
€2,651,510 |
-43.1% |
€4,661,813 |
|
Trade Debtors |
€192,076 |
-53.2% |
€410,385 |
28.2% |
€320,189 |
14.7% |
€279,258 |
-11% |
€313,794 |
|
Cash |
€421,459 |
-70.2% |
€1,413,488 |
110.8% |
€670,647 |
8.4% |
€618,414 |
76.9% |
€349,681 |
|
Other Debtors |
€7,329,235 |
138.5% |
€3,073,642 |
-24.2% |
€4,053,271 |
2.5% |
€3,954,961 |
78.3% |
€2,217,579 |
|
Miscellaneous Current Assets |
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
Total Current Assets |
€11,136,083 |
42.8% |
€7,799,344 |
-18.7% |
€9,587,765 |
27.8% |
€7,504,143 |
-0.5% |
€7,542,867 |
|
Trade Creditors |
€617,785 |
29.9% |
€475,675 |
-54.5% |
€1,045,706 |
14.7% |
€911,627 |
68.9% |
€539,779 |
|
Bank Loans & Overdrafts |
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
Other Short Term Finance |
€1,585,709 |
18.4% |
€1,339,071 |
397.5% |
€269,146 |
90.5% |
€141,306 |
-61.9% |
€370,725 |
|
Miscellaneous Current Liabilities |
€1,112,195 |
3.3% |
€1,076,568 |
74.2% |
€617,943 |
28% |
€482,761 |
-25.9% |
€651,435 |
|
Total Current Liabilities |
€3,315,689 |
14.7% |
€2,891,314 |
49.6% |
€1,932,795 |
25.9% |
€1,535,694 |
-1.7% |
€1,561,939 |
|
Bank Loans & Overdrafts and LTL |
€6,426,934 |
-26.1% |
€8,702,232 |
-50.5% |
€17,596,777 |
- |
€17,596,777 |
- |
€17,596,777 |
|
Other Long Term Finance |
€6,426,934 |
-26.1% |
€8,702,232 |
-50.5% |
€17,596,777 |
- |
€17,596,777 |
- |
€17,596,777 |
|
Total Long Term Liabilities |
€6,426,934 |
-26.1% |
€8,702,232 |
-50.5% |
€17,596,777 |
- |
€17,596,777 |
- |
€17,596,777 |
|
Date Of |
31/12/13 |
(%) |
31/12/12 |
(%) |
31/12/11 |
(%) |
31/12/10 |
(%) |
31/12/09 |
|
Accounts |
|
|
|
|
|
|
|
|
|
|
Called Up Share Capital |
€1,772,650 |
- |
€1,772,650 |
- |
€1,772,650 |
- |
€1,772,650 |
- |
€1,772,650 |
|
P & L Account Reserve |
€861,170 |
120.2% |
-€4,263,560 |
29.9% |
-€6,084,653 |
9.3% |
-€6,705,088 |
-25.2% |
-€5,356,961 |
|
Revaluation Reserve |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Sundry Reserves |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Shareholder |
€2,633,820 |
205.7% |
-€2,490,910 |
42.2% |
-€4,312,003 |
12.6% |
-€4,932,438 |
-37.6% |
-€3,584,311 |
|
Funds |
|
|
|
|
|
|
|
|
|
|
Date
Of |
31/12/13 |
(%) |
31/12/12 |
(%) |
31/12/11 |
(%) |
31/12/10 |
(%) |
31/12/09 |
|
Accounts |
|
|
|
|
|
|
|
|
|
|
Net
Worth |
€2,633,820 |
205.7% |
-€2,490,910 |
47.4% |
-€4,733,184 |
22.4% |
-€6,100,744 |
-8.7% |
-€5,610,239 |
|
Working
Capital |
€7,820,394 |
59.3% |
€4,908,030 |
-35.9% |
€7,654,970 |
28.3% |
€5,968,449 |
-0.2% |
€5,980,928 |
|
Total
Assets |
€12,376,443 |
36% |
€9,102,636 |
-40.2% |
€15,217,569 |
7.2% |
€14,200,033 |
-8.8% |
€15,574,405 |
|
Total
Liabilities |
€9,742,623 |
-16% |
€11,593,546 |
-40.6% |
€19,529,572 |
2.1% |
€19,132,471 |
-0.1% |
€19,158,716 |
|
Net
Assets |
€2,633,820 |
205.7% |
-€2,490,910 |
42.2% |
-€4,312,003 |
12.6% |
-€4,932,438 |
-37.6% |
-€3,584,311 |
|
Date Of |
31/12/13 |
(%) |
31/12/12 |
(%) |
31/12/11 |
(%) |
31/12/10 |
(%) |
31/12/09 |
|
Accounts |
|
|
|
|
|
|
|
|
|
|
Contingent Liability |
NO |
- |
NO |
- |
NO |
- |
YES |
- |
YES |
|
Capital Employed |
€9,060,754 |
45.9% |
€6,211,322 |
-53.2% |
€13,284,774 |
4.9% |
€12,664,339 |
-9.6% |
€14,012,466 |
|
Number of Employees |
58 |
-38.9% |
95 |
-12% |
108 |
8% |
100 |
- |
100 |
|
Auditors |
DELOITTE & TOUCHE |
|
Auditor |
|
|
|
The audit report contains no
adverse comments |
|
Comments |
|
|
Bankers |
BANK OF IRELAND |
|
Bank Branch Code |
90-38-67 |
|
Date Of Accounts |
31/12/13 |
31/12/12 |
31/12/11 |
31/12/10 |
31/12/09 |
|
Pre-tax
Profit margin % |
34.29 |
9.32 |
2.15 |
-7.33 |
1.08 |
|
Current ratio |
3.36 |
2.70 |
4.96 |
4.89 |
4.83 |
|
Sales/Net
Working Capital |
1.98 |
4.27 |
2.69 |
3.03 |
2.84 |
|
Gearing % |
244 |
-349.40 |
-408.10 |
-356.80 |
-490.90 |
|
Equity in % |
21.30 |
-27.40 |
-29.10 |
-37.80 |
-26.50 |
|
Creditor Days |
14.54 |
8.27 |
18.48 |
18.32 |
11.58 |
|
Debtor Days |
4.52 |
7.13 |
5.65 |
5.61 |
6.73 |
|
Liquidity/Acid
Test |
2.39 |
1.69 |
2.60 |
3.15 |
1.84 |
|
Return On |
|
|
|
|
|
|
Capital Employed % |
58.51 |
31.40 |
3.33 |
-10.48 |
1.30 |
|
Return On Total |
|
|
|
|
|
|
Assets Employed % |
42.83 |
21.42 |
2.91 |
-9.34 |
1.17 |
|
Current Debt
Ratio |
1.25 |
-1.16 |
-0.44 |
-0.31 |
-0.43 |
|
Total Debt Ratio |
3.69 |
-4.65 |
-4.52 |
-3.87 |
-5.34 |
|
Stock
Turnover Ratio % |
20.65 |
13.86 |
22.06 |
14.64 |
27.48 |
|
Return on Net |
|
|
|
|
|
|
Assets Employed % |
201.28 |
-78.31 |
-10.28 |
26.90 |
-5.11 |
Previous
Company Names
|
||
|
Date |
|
Previous Name |
|
N/A |
|
VIASYS IRELAND HOLDINGS LIMITED |
Received Documents Writ Details
No writs found
|
Statistics |
|
Summary |
|
|
Group |
6 companies |
|
NATUS HEALTHCARE |
|
|
|
Holding Company |
TECHNOLOGIES IRELAND |
|
Linkages |
21 companies |
|
HOLDING II LIMITED |
|
|
|
|
|
|
Countries |
In 7 countries |
|
|
|
|
|
Ownership Status |
Wholly Owned |
|
|
|
Ultimate Holding Company |
NATUS MEDICAL INCORPORATED |
|
Company Name |
Registered |
Latest Key |
Consol. |
Turnover |
|
|
Number |
Financials |
Accounts |
|
|
NATUS MEDICAL INCORPORATED |
|
- |
- |
$355,834,000 |
|
NATUS HEALTHCARE TECHN... |
IE514279 |
31.12.2013 |
N |
|
|
NATUS HEALTHCARE TEC... |
IE514280 |
31.12.2013 |
|
|
|
NATUS MANUFACTURIN... |
IE422983 |
31.12.2013 |
N |
€15,459,739 |
|
NATUS NICOLET U.K... |
02986787 |
31.12.2013 |
N |
£10,259,906 |
|
NATUS NEONATAL LIMITED |
04090239 |
31.12.2013 |
N |
|
Other
Linked Companies
|
||
|
Name |
Latest Key Financials |
Turnover |
|
NATUS EUROPE GMBH |
31.12.2013 |
€25,900,875 |
|
NEOMETRICS INC |
- |
|
|
OLYMPIC MEDICAL CORP |
- |
|
|
BIO-LOGIC SYSTEMS CORP |
- |
$21,000,000 |
|
NICOLET VASCULAR |
- |
|
|
HAWAII MEDICAL, LLC |
- |
|
|
EMBLA SYSTEMS, LLC |
- |
$30,000,000 |
|
NEUROCOM INTERNATIONAL, INC |
- |
$4,139,000 |
|
ALPINE BIOMED CORP |
- |
$35,000,000 |
|
NATUS ACQUISITION CORP |
- |
$3,143,000 |
|
GRASS TECHNOLOGIES CORP |
- |
|
|
GLOBAL NEURO-DIAGNOSTICS, LP |
- |
|
|
SONA MED CORP |
- |
$2,688,000 |
|
ALPINE APS |
- |
|
|
DELTAMED S.A |
- |
|
|
EMBLA SYSTEMS, LTD |
- |
|
|
EXCEL TECH LTD |
- |
|
|
MEDIX I.C.S.A |
- |
|
|
NATUS EUROPE GMBH |
- |
|
|
NATUS NEUROLOGY INCORPORATED |
- |
|
|
1 |
|
|
Previous
Director/Company Secretaries
|
||
|
Name |
Current Directorships |
Previous Directorships |
|
JOHN JORDAN |
0 |
5 |
|
JOHN JORDAN |
0 |
1 |
|
PADRAIG BARRY |
0 |
5 |
|
PADRAIG BARRY |
0 |
5 |
|
JOHN IMPERATO |
0 |
2 |
|
GIULIO PERILLO |
0 |
2 |
|
RALF LOTHER |
1 |
1 |
|
JEAN MICHEL XAVIER DECKERS |
0 |
1 |
|
JORGE MARIO GOMEZ AGUDELO |
0 |
1 |
|
JEAN BURARA MASCHAL |
0 |
1 |
|
ANTONY PAUL KUSHNER |
0 |
1 |
|
JAMES FREDERICK HINRICHS |
0 |
1 |
|
Average Invoice Value |
n/a |
|
Invoices available |
n/a |
|
Paid |
n/a |
|
Outstanding |
n/a |
Trade Payment Data is information
that we collect from selected third
party partners who send us information
about their whole sales ledger.
Within Terms 0-30
Days 31-60 Days 61-90 Days 91+ Days
Paid
Outstanding
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.96 |
|
UK Pound |
1 |
Rs.99.93 |
|
Euro |
1 |
Rs.70.16 |
INFORMATION DETAILS
|
Analysis Done by
: |
KAS |
|
|
|
|
Report Prepared
by : |
ASH |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.